Some positive news from AOTI (LON: AOTI) with additional data on its TWO2 treatment showing effectiveness in treatment of hard to heal wounds and a low level of recurrence. Hospitalisations and amputations were low. AOTI is still awaiting the CMS coverage determination for the wider Medicaid population in the US. That will give greater access to the treatment. The share price rebounded 48.2% to 63p.
Stonehage Fleming Investment Management increased has taken a 6.1% stake in Dianomi (LON: DNM). The share price improved 28.6% to 18p.
A positive trading statement by IG Design (LON: IGR) has led to upgrades for the year just ended and the current year. Ongoing gift wrap and stationery business is better than expected, although consumer confidence remains weak. In the year to March 2026, revenues were $292m, while the pre-tax profit estimate has been increased from $9.5m to $11.5m. This year’s pre-tax profit forecast has been raised from $12.3m to $14.3m, helped by an earnings enhancing acquisition in South Africa. Net cash is $72m before the £3.4m spent on the acquisition. The share price recovered 27.8% to 69.5p.
Professional services provider Christie Group (LON: CTG) beat previously upgraded profit forecasts for 2025. Pre-tax profit jumped from £2.6m to £6m, helped by the sale of loss making operations, and the dividend was raised 56% to 3.5p/share. Additional hires will increase costs this year, so profit is forecast to fall to £4.6m. The share price rose by one-quarter to 150p, which is 11 times prospective 2026 earnings.
FALLERS
Sexual dysfunction treatments developer Futura Medical (LON: FUM) is putting its new strategy into force by cutting costs and focusing on a more commercial approach. Female sexual dysfunction treatment WSD4000 has significant potential, and a phase 3 trial could start before the end of the year. Potential partners are in talks with the company. There was £3.4m in the bank at the end of 2025 and this should last until June. The previously highlighted milestone payment from Haleon for achieving the Eroxon patent in the US has still to be paid, but management is confident that it has been triggered. This cash should come in before June and would last until the end of the year. Alternative funding options are being assessed just in case the Haleon payment is not made before June. The share price dived 48.6% to 0.746p.
GenIP (LON: GNIP) is raising £350,000 at 7p/share and the cash will be used to fund new product development and additional staff. Earlier in the week, GenIP announced a strategic alliance with US-based professional services provider Cardinal IP. The two companies will sell each other’s products. CMC has been appointed as joint broker. The share price fell 33.2% to 6.85p.
Celsius Resources (LON: CLA) continues to make progress with the Maalinao-Caigutan-Biyog Copper-Gold project and the development of the mine and process plant, which is out for tender. Equinaire Holdings says it acquired the loan held by Makilala Mining Company in order to become involved in offtake arrangements. The share price slipped 29.2% to 0.46p.
ProService Building Services Marketplace (LON: PRO), formerly HSS Hire, says 2025-26 revenues from continuing operations is expected to be £248m, which is lower than forecast. That is due to a lower ramping up of the new arrangements with Speedy Hire and the weak construction market. The company is investing in further automation of its marketplace platform. Speedy Hire volumes are improving, and the deal should be earnings enhancing this year. Net debt was £27.2m at the end of March 2026 and the debt should be refinanced by August. Guidance for 2026-27 EBITDA is between £9m and £12m. Consensus was previously £19.6m. The share price declined 23.5% to 3.275p.